Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-094518
Filing Date
2025-09-29
Accepted
2025-09-29 16:30:48
Documents
22
Period of Report
2025-11-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A cydy-20251121xdef14a.htm   iXBRL DEF 14A 788637
2 GRAPHIC cydy-20251121xdef14a_a005.jpg GRAPHIC 7383
3 GRAPHIC cydy-20251121xdef14a_a007.jpg GRAPHIC 6624
4 GRAPHIC cydy-20251121xdef14a_bg001.jpg GRAPHIC 181189
5 GRAPHIC cydy-20251121xdef14a_bg002.jpg GRAPHIC 142509
6 GRAPHIC cydy-20251121xdef14a_cg001.jpg GRAPHIC 154798
7 GRAPHIC cydy-20251121xdef14a_cg002.jpg GRAPHIC 166186
  Complete submission text file 0001104659-25-094518.txt   3801563

Data Files

Seq Description Document Type Size
8 EX-101.SCH cydy-20251121.xsd EX-101.SCH 4357
9 EX-101.DEF cydy-20251121_def.xml EX-101.DEF 5268
10 EX-101.LAB cydy-20251121_lab.xml EX-101.LAB 8497
11 EX-101.PRE cydy-20251121_pre.xml EX-101.PRE 6307
24 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20251121xdef14a_htm.xml XML 513720
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-49908 | Film No.: 251356542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)